Enhancing the Efficiency of Mild-Temperature Photothermal Therapy for Cancer Assisting with Various Strategies
Abstract
:1. Introduction
2. The Mechanism of MTPTT
3. Various Approaches to Improve the Efficacy of MTPTT
3.1. Heat Shock Proteins Inhibitors
3.2. siRNA
3.3. Nucleus Damage
3.4. Energy Inhibition
3.5. Autophagy Mediation
4. The Synergistic-Therapy Strategies
4.1. Chemotherapy
4.2. Radiotherapy
4.3. Photodynamic Therapy
4.4. Gas Therapy
4.5. Immunotherapy
5. Summary and Perspectives
Author Contributions
Funding
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- Hildebrandt, B.; Wust, P.; Ahlers, O.; Dieing, A.; Sreenivasa, G.; Kerner, T.; Felix, R.; Riess, H. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol./Hematol. 2002, 43, 33–56. [Google Scholar] [CrossRef]
- Vaupel, P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 2004, 14, 198–206. [Google Scholar] [CrossRef] [PubMed]
- Chu, K.F.; Dupuy, D.E. Thermal ablation of tumours: Biological mechanisms and advances in therapy. Nat. Rev. Cancer 2014, 14, 199–208. [Google Scholar] [CrossRef] [PubMed]
- Nakayama, M.; Okano, T.; Miyazaki, T.; Kohori, F.; Sakai, K.; Yokoyama, M. Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. J. Control. Release 2006, 115, 46–56. [Google Scholar] [CrossRef] [PubMed]
- Deng, X.; Li, K.; Cai, X.; Liu, B.; Wei, Y.; Deng, K.; Xie, Z.; Wu, Z.; Ma, P.; Hou, Z.; et al. A Hollow-Structured CuS@Cu2S@Au Nanohybrid: Synergistically Enhanced Photothermal Efficiency and Photoswitchable Targeting Effect for Cancer Theranostics. Adv. Mater. 2017, 29, 1701266–1701274. [Google Scholar] [CrossRef] [PubMed]
- Li, X.; Lovell, J.F.; Yoon, J.; Chen, X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat. Rev. Clin. Oncol. 2020, 17, 657–674. [Google Scholar] [CrossRef]
- Zhang, Y.; Yang, D.; Chen, H.; Lim, W.Q.; Phua, F.S.Z.; An, G.; Yang, P.; Zhao, Y. Reduction-sensitive fluorescence enhanced polymeric prodrug nanoparticles for combinational photothermal-chemotherapy. Biomaterials 2018, 163, 14–24. [Google Scholar] [CrossRef]
- Melamed, J.R.; Edelstein, R.S.; Day, E.S. Elucidating the Fundamental Mechanisms of Cell Death Triggered by Photothermal Therapy. ACS Nano 2015, 9, 6–11. [Google Scholar] [CrossRef]
- Kim, J.; Kim, J.; Jeong, C.; Kim, W.J. Synergistic nanomedicine by combined gene and photothermal therapy. Adv. Drug Deliv. Rev. 2016, 98, 99–112. [Google Scholar] [CrossRef]
- Jha, S.; Sharma, P.K.; Malviya, R. Hyperthermia: Role and Risk Factor for Cancer Treatment. Achiev. Life Sci. 2016, 10, 161–167. [Google Scholar] [CrossRef]
- Ren, W.; Yan, Y.; Zeng, L.; Shi, Z.; Gong, A.; Schaaf, P.; Wang, D.; Zhao, J.; Zou, B.; Yu, H.; et al. A Near Infrared Light Triggered Hydrogenated Black TiO2 for Cancer Photothermal Therapy. Adv. Healthc. Mater. 2015, 4, 1526–1536. [Google Scholar] [CrossRef]
- Liu, Y.; Shu, G.; Li, X.; Chen, H.; Zhang, B.; Pan, H.; Li, T.; Gong, X.; Wang, H.; Wu, X.; et al. Human HSP70 Promoter-Based Prussian Blue Nanotheranostics for Thermo-Controlled Gene Therapy and Synergistic Photothermal Ablation. Adv. Funct. Mater. 2018, 28, 1802026. [Google Scholar] [CrossRef]
- Zheng, M.; Yue, C.; Ma, Y.; Gong, P.; Zhao, P.; Zheng, C.; Sheng, Z.; Zhang, P.; Wang, Z.; Cai, L. Single-Step Assembly of DOX/ICG Loaded Lipid–Polymer Nanoparticles for Highly Effective Chemo-photothermal Combination Therapy. ACS Nano 2013, 7, 2056–2067. [Google Scholar] [CrossRef]
- Sun, C.; Wen, L.; Zeng, J.; Wang, Y.; Sun, Q.; Deng, L.; Zhao, C.; Li, Z. One-pot solventless preparation of PEGylated black phosphorus nanoparticles for photoacoustic imaging and photothermal therapy of cancer. Biomaterials 2016, 91, 81–89. [Google Scholar] [CrossRef]
- Chen, J.; Ning, C.; Zhou, Z.; Yu, P.; Zhu, Y.; Tan, G.; Mao, C. Nanomaterials as photothermal therapeutic agents. Prog. Mater. Sci. 2019, 99, 1–26. [Google Scholar] [CrossRef]
- Sun, H.; Su, J.; Meng, Q.; Yin, Q.; Chen, L.; Gu, W.; Zhang, Z.; Yu, H.; Zhang, P.; Wang, S.; et al. Cancer Cell Membrane-Coated Gold Nanocages with Hyperthermia-Triggered Drug Release and Homotypic Target Inhibit Growth and Metastasis of Breast Cancer. Adv. Funct. Mater. 2016, 30, 1910230. [Google Scholar] [CrossRef]
- Ma, Z.; Zhang, Y.; Zhang, J.; Zhang, W.; Foda, M.F.; Dai, X.; Han, H. Ultrasmall Peptide-Coated Platinum Nanoparticles for Precise NIR-II Photothermal Therapy by Mitochondrial Targeting. ACS Appl. Mater. Interfaces 2020, 12, 39434–39443. [Google Scholar] [CrossRef]
- Fan, W.; Yung, B.; Huang, P.; Chen, X. Nanotechnology for Multimodal Synergistic Cancer Therapy. Chem. Rev. 2017, 117, 13566–13638. [Google Scholar] [CrossRef]
- Hauck, T.S.; Jennings, T.L.; Yatsenko, T.; Kumaradas, J.C.; Chan, W.C.W. Enhancing the Toxicity of Cancer Chemotherapeutics with Gold Nanorod Hyperthermia. Adv. Mater. 2008, 20, 3832–3838. [Google Scholar] [CrossRef]
- Zhang, Y.; Hou, Z.; Ge, Y.; Deng, K.; Liu, B.; Li, X.; Li, Q.; Cheng, Z.; Ma, P.; Li, C.; et al. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery. ACS Appl. Mater. Interfaces 2015, 7, 20696–20706. [Google Scholar] [CrossRef]
- Sun, X.; Wang, C.; Gao, M.; Hu, A.; Liu, Z. Remotely controlled red blood cell carriers for cancer targeting and near-infrared light-triggered drug release in combined photothermal chemotherapy. Nanomed. Nanotechnol. Biol. Med. 2016, 12, 548. [Google Scholar] [CrossRef]
- Feng, L.; Li, K.; Shi, X.; Gao, M.; Liu, J.; Liu, Z. Smart pH-Responsive Nanocarriers Based on Nano-Graphene Oxide for Combined Chemo- and Photothermal Therapy Overcoming Drug Resistance. Adv. Healthc. Mater. 2014, 3, 1261–1271. [Google Scholar] [CrossRef] [PubMed]
- Chen, Q.; Liang, C.; Wang, C.; Liu, Z. An Imagable and Photothermal “Abraxane-Like” Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast Tumors. Adv. Mater. 2014, 27, 903–910. [Google Scholar] [CrossRef] [PubMed]
- Zhou, F.; Wu, S.; Song, S.; Chen, W.R.; Resasco, D.E.; Xing, D. Antitumor immunologically modified carbon nanotubes for photothermal therapy. Biomaterials 2012, 33, 3235–3242. [Google Scholar] [CrossRef] [PubMed]
- Tao, Y.; Ju, E.; Ren, J.; Qu, X. Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy. Biomaterials 2014, 35, 9963–9971. [Google Scholar] [CrossRef]
- Wang, P.; Jiang, F.; Chen, B.; Tang, H.; Zeng, X.; Cai, D.; Zhu, M.; Long, R.; Yang, D.; Kankala, R.K.; et al. Bioinspired red blood cell membrane-encapsulated biomimetic nanoconstructs for synergistic and efficacious chemo-photothermal therapy. Colloids Surf. B Biointerfaces 2020, 189, 110842. [Google Scholar] [CrossRef]
- Thomas, R.J.; Rockwell, B.A.; Marshall, W.J.; Aldrich, R.C.; Zimmerman, S.A.; Rockwell, R.J. A procedure for multiple-pulse maximum permissible exposure determination under the Z136.1-2000 American National Standard for Safe Use of Lasers. J. Laser Appl. 2001, 13, 134–140. [Google Scholar] [CrossRef]
- Hu, J.-J.; Cheng, Y.-J.; Zhang, X.-Z. Recent advances in nanomaterials for enhanced photothermal therapy of tumors. Nanoscale 2018, 10, 22657–22672. [Google Scholar] [CrossRef]
- Zhou, J.; Li, M.; Hou, Y.; Luo, Z.; Chen, Q.; Cao, H.; Huo, R.; Xue, C.; Sutrisno, L.; Hao, L.; et al. Engineering of a Nanosized Biocatalyst for Combined Tumor Starvation and Low-Temperature Photothermal Therapy. ACS Nano 2018, 12, 2858–2872. [Google Scholar] [CrossRef]
- Diogo, D.M.D.M.; Pais-Silva, C.; Dias, D.R.; Moreira, A.F.; Correia, I.J. Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials. Adv. Healthc. Mater. 2017, 6, 1700073. [Google Scholar] [CrossRef]
- Deng, X.; Shao, Z.; Zhao, Y. Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy. Adv. Sci. 2021, 8, 2002504. [Google Scholar] [CrossRef]
- Deng, X.; Guan, W.; Qing, X.; Yang, W.; Que, Y.; Tan, L.; Liang, H.; Zhang, Z.; Wang, B.; Liu, X.; et al. Ultrafast Low-Temperature Photothermal Therapy Activates Autophagy and Recovers Immunity for Efficient Antitumor Treatment. ACS Appl. Mater. Interfaces 2020, 12, 4265–4275. [Google Scholar] [CrossRef]
- Ding, F.; Gao, X.; Huang, X.; Ge, H.; Xie, M.; Qian, J.; Song, J.; Li, Y.; Zhu, X.; Zhang, C. Polydopamine-coated nucleic acid nanogel for siRNA-mediated low-temperature photothermal therapy. Biomaterials 2020, 245, 119976. [Google Scholar] [CrossRef]
- Diederich, C.J. Thermal ablation and high-temperature thermal therapy: Overview of technology and clinical implementation. Int. J. Hyperth. 2005, 21, 745–753. [Google Scholar] [CrossRef]
- Jaque, D.; Martínez Maestro, L.; del Rosal, B.; Haro-Gonzalez, P.; Benayas, A.; Plaza, J.L.; Rodríguez, E.M.; Solé, J.G. Nanoparticles for photothermal therapies. Nanoscale 2014, 6, 9494–9530. [Google Scholar] [CrossRef]
- Li, G.C.; Mivechi, N.F.; Weitzel, G. Heat shock proteins, thermotolerance, and their relevance to clinical hyperthermia. Int. J. Hyperth. 1995, 11, 459–488. [Google Scholar] [CrossRef]
- Zou, Q.; Abbas, M.; Zhao, L.; Li, S.; Shen, G.; Yan, X. Biological Photothermal Nanodots Based on Self-Assembly of Peptide–Porphyrin Conjugates for Antitumor Therapy. J. Am. Chem. Soc. 2017, 139, 1921–1927. [Google Scholar] [CrossRef]
- Calderwood, S.K.; Gong, J. Heat Shock Proteins Promote Cancer: It’s a Protection Racket. Trends Biochem. Sci. 2016, 41, 311–323. [Google Scholar] [CrossRef] [Green Version]
- Fuller, K.; Issels, R.; Slosman, D.; Guillet, J.-G.; Soussi, T.; Polla, B. Cancer and the heat shock response. Eur. J. Cancer 1994, 30, 1884–1891. [Google Scholar] [CrossRef]
- Caccamo, A.E.; Desenzani, S.; Belloni, L.; Borghetti, A.F.; Bettuzzi, S. Nuclear clusterin accumulation during heat shock response: Implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells. J. Cell. Physiol. 2006, 207, 208–219. [Google Scholar] [CrossRef]
- Wang, S.; Xin, J.; Zhang, L.; Zhou, Y.; Yao, C.; Wang, B.; Wang, J.; Zhang, Z. Cantharidin-encapsulated thermal-sensitive liposomes coated with gold nanoparticles for enhanced photothermal therapy on A431 cells. Int. J. Nanomed. 2018, 13, 2143–2160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Elmallah, M.I.; Cordonnier, M.; Vautrot, V.; Chanteloup, G.; Garrido, C.; Gobbo, J. Membrane-anchored heat-shock protein 70 (Hsp70) in cancer. Cancer Lett. 2019, 469, 134–141. [Google Scholar] [CrossRef] [PubMed]
- Kumar, S.; Stokes, J.; Singh, U.P.; Gunn, K.S.; Acharya, A.; Manne, U.; Mishra, M. Targeting Hsp70: A possible therapy for cancer. Cancer Lett. 2016, 374, 156–166. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wu, J.; Liu, T.; Rios, Z.; Mei, Q.; Lin, X.; Cao, S. Heat Shock Proteins and Cancer. Trends Pharmacol. Sci. 2017, 38, 226–256. [Google Scholar] [CrossRef] [PubMed]
- Daugaard, M.; Rohde, M.; Jäättelä, M. The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions. FEBS Lett. 2007, 581, 3702–3710. [Google Scholar] [CrossRef] [Green Version]
- Hennessy, F.; Nicoll, W.S.; Zimmermann, R.; Cheetham, M.E.; Blatch, G.L. Not all J domains are created equal: Implications for the specificity of Hsp40-Hsp70 interactions. Protein Sci. 2005, 14, 1697–1709. [Google Scholar] [CrossRef] [Green Version]
- Bukau, B.; Weissman, J.; Horwich, A. Molecular Chaperones and Protein Quality Control. Cell 2006, 125, 443–451. [Google Scholar] [CrossRef] [Green Version]
- Vogel, M.; Bukau, B.; Mayer, M.P. Allosteric Regulation of Hsp70 Chaperones by a Proline Switch. Mol. Cell 2006, 21, 359–367. [Google Scholar] [CrossRef]
- Rauch, J.N.; Tse, E.; Freilich, R.; Mok, S.-A.; Makley, L.N.; Southworth, D.R.; Gestwicki, J.E. BAG3 Is a Modular, Scaffolding Protein that physically Links Heat Shock Protein 70 (Hsp70) to the Small Heat Shock Proteins. J. Mol. Biol. 2017, 429, 128–141. [Google Scholar] [CrossRef] [Green Version]
- Sherman, M.Y.; Gabai, V. The role of Bag3 in cell signaling. J. Cell. Biochem. 2021, 123, 43–53. [Google Scholar] [CrossRef]
- Colvin, T.A.; Gabai, V.L.; Gong, J.; Calderwood, S.K.; Li, H.; Gummuluru, S.; Matchuk, O.N.; Smirnova, S.G.; Orlova, N.V.; Zamulaeva, I.A.; et al. Hsp70–Bag3 Interactions Regulate Cancer-Related Signaling Networks. Cancer Res. 2014, 74, 4731–4740. [Google Scholar] [CrossRef] [Green Version]
- Tao, W.; Ji, X.; Zhu, X.; Li, L.; Wang, J.; Zhang, Y.; Saw, P.E.; Li, W.; Kong, N.; Islam, M.A.; et al. Two-Dimensional Antimonene-Based Photonic Nanomedicine for Cancer Theranostics. Adv. Mater. 2018, 30, e1802061. [Google Scholar] [CrossRef]
- Gao, F.-P.; Lin, Y.-X.; Li, L.-L.; Liu, Y.; Mayerhöffer, U.; Spenst, P.; Su, J.-G.; Li, J.-Y.; Würthner, F.; Wang, H. Supramolecular adducts of squaraine and protein for noninvasive tumor imaging and photothermal therapy in vivo. Biomaterials 2014, 35, 1004–1014. [Google Scholar] [CrossRef]
- Ali, M.R.; Ali, H.R.; Rankin, C.R.; El-Sayed, M.A. Targeting heat shock protein 70 using gold nanorods enhances cancer cell apoptosis in low dose plasmonic photothermal therapy. Biomaterials 2016, 102, 1–8. [Google Scholar] [CrossRef]
- Mizushima, N.; Komatsu, M. Autophagy: Renovation of Cells and Tissues. Cell 2011, 147, 728–741. [Google Scholar] [CrossRef] [Green Version]
- Amaravadi, R.K.; Kimmelman, A.C.; Debnath, J. Targeting Autophagy in Cancer: Recent Advances and Future Directions. Cancer Discov. 2019, 9, 1167–1181. [Google Scholar] [CrossRef] [Green Version]
- Liang, S.; Li, X.; Gao, C.; Zhang, L. microRNA-based autophagy inhibition as targeted therapy in pancreatic cancer. Biomed. Pharm. 2020, 132, 110799. [Google Scholar] [CrossRef]
- Yang, Z.J.; Chee, C.E.; Huang, S.; Sinicrope, F.A. The Role of Autophagy in Cancer: Therapeutic Implications. Mol. Cancer Ther. 2011, 10, 1533–1541. [Google Scholar] [CrossRef] [Green Version]
- Chude, C.I.; Amaravadi, R.K. Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors. Int. J. Mol. Sci. 2017, 18, 1279. [Google Scholar] [CrossRef] [Green Version]
- Chen, X.; Tong, R.; Shi, Z.; Yang, B.; Liu, H.; Ding, S.; Wang, X.; Lei, Q.; Wu, J.; Fang, W. MOF Nanoparticles with Encapsulated Autophagy Inhibitor in Controlled Drug Delivery System for Antitumor. ACS Appl. Mater. Interfaces 2018, 10, 2328–2337. [Google Scholar] [CrossRef]
- Ichimiya, T.; Yamakawa, T.; Hirano, T.; Yokoyama, Y.; Hayashi, Y.; Hirayama, D.; Wagatsuma, K.; Itoi, T.; Nakase, H. Autophagy and Autophagy-Related Diseases: A Review. Int. J. Mol. Sci. 2020, 21, 8974. [Google Scholar] [CrossRef] [PubMed]
- Zhu, Y.-X.; Jia, H.-R.; Gao, G.; Pan, G.-Y.; Jiang, Y.-W.; Li, P.; Zhou, N.; Li, C.; She, C.; Ulrich, N.W.; et al. Mitochondria-acting nanomicelles for destruction of cancer cells via excessive mitophagy/autophagy-driven lethal energy depletion and phototherapy. Biomaterials 2020, 232, 119668. [Google Scholar] [CrossRef] [PubMed]
- Kang, R.; Zeh, H.J.; Lotze, M.T.; Tang, D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011, 18, 571–580. [Google Scholar] [CrossRef] [PubMed]
- Debenedetti, A.; Baglioni, C. Translational regulation of the synthesis of a major heat-shock protein in HeLa Cells. J. Biol. Chem. 1986, 261, 5800–5804. [Google Scholar]
- Liu, T.; Daniels, C.K.; Cao, S. Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential. Pharmacol. Ther. 2012, 136, 354–374. [Google Scholar] [CrossRef]
- Street, T.O.; Lavery, L.A.; Agard, D.A. Substrate Binding Drives Large-Scale Conformational Changes in the Hsp90 Molecular Chaperone. Mol. Cell 2011, 42, 96–105. [Google Scholar] [CrossRef] [Green Version]
- Sauvage, F.; Messaoudi, S.; Fattal, E.; Barratt, G.; Vergnaud-Gauduchon, J. Heat shock proteins and cancer: How can nanomedicine be harnessed? J. Control. Release 2017, 248, 133–143. [Google Scholar] [CrossRef]
- Yang, Y.; Zhu, W.; Dong, Z.; Chao, Y.; Xu, L.; Chen, M.; Liu, Z. 1D Coordination Polymer Nanofibers for Low-Temperature Photothermal Therapy. Adv. Mater. 2017, 29, 1703588–1703600. [Google Scholar] [CrossRef]
- Wu, J.; Bremner, D.H.; Niu, S.; Shi, M.; Wang, H.; Tang, R.; Zhu, L.-M. Chemodrug-Gated Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Multimodal Imaging-Guided Low-Temperature Photothermal Therapy/Chemotherapy of Cancer. ACS Appl. Mater. Interfaces 2018, 10, 42115–42126. [Google Scholar] [CrossRef]
- Yang, G.-G.; Zhou, D.-J.; Pan, Z.-Y.; Yang, J.; Zhang, D.-Y.; Cao, Q.; Ji, L.-N.; Mao, Z.-W. Multifunctional low-temperature photothermal nanodrug with in vivo clearance, ROS-Scavenging and anti-inflammatory abilities. Biomaterials 2019, 216, 119280. [Google Scholar] [CrossRef]
- Wang, D.; Zhou, J.; Chen, R.; Shi, R.; Zhao, G.; Xia, G.; Li, R.; Liu, Z.; Tian, J.; Wang, H.; et al. Controllable synthesis of dual-MOFs nanostructures for pH-responsive artemisinin delivery, magnetic resonance and optical dual-model imaging-guided chemo/photothermal combinational cancer therapy. Biomaterials 2016, 100, 27–40. [Google Scholar] [CrossRef]
- Zhang, L.; Yi, Y.; Chen, J.; Sun, Y.; Guo, Q.; Zheng, Z.; Song, S. Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells. Biochem. Biophys. Res. Commun. 2010, 403, 282–287. [Google Scholar] [CrossRef]
- Kashyap, D.; Mondal, R.; Tuli, H.S.; Kumar, G.; Sharma, A.K. Molecular targets of gambogic acid in cancer: Recent trends and advancements. Tumor Biol. 2016, 37, 12915–12925. [Google Scholar] [CrossRef]
- Gao, G.; Jiang, Y.; Sun, W.; Guo, Y.; Jia, H.; Yu, X.; Pan, G.; Wu, F. Molecular Targeting-Mediated Mild-Temperature Photothermal Therapy with a Smart Albumin-Based Nanodrug. Small 2019, 15, e1900501. [Google Scholar] [CrossRef]
- Raja, S.M.; Clubb, R.J.; Bhattacharyya, M.; Dimri, M.; Cheng, H.; Pan, W.; Ortega-Cava, C.; Lakku-Reddi, A.; Naramura, M.; Band, V.; et al. A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells. Cancer Biol. Ther. 2008, 7, 1630–1640. [Google Scholar] [CrossRef] [Green Version]
- Li, Y.; Chen, Y.; Qiu, C.; Ma, X.; Lei, K.; Cai, G.; Liang, X.; Liu, J. 17-allylamino-17-demethoxygeldanamycin impeded chemotherapy through antioxidant activation via reducing reactive oxygen species-induced cell death. J. Cell. Biochem. 2018, 120, 1560–1576. [Google Scholar] [CrossRef]
- Zhang, J.; Zheng, Z.; Zhao, Y.; Zhang, T.; Gu, X.; Yang, W. The heat shock protein 90 inhibitor 17-AAG suppresses growth and induces apoptosis in human cholangiocarcinoma cells. Clin. Exp. Med. 2013, 13, 323–328. [Google Scholar] [CrossRef]
- Tian, H.; Zhang, J.; Zhang, H.; Jiang, Y.; Song, A.; Luan, Y. Low side-effect and heat-shock protein-inhibited chemo-phototherapy nanoplatform via co-assembling strategy of biotin-tailored IR780 and quercetin. Chem. Eng. J. 2019, 382, 123043. [Google Scholar] [CrossRef]
- Feng, Y.; Ling, P.; Zhai, G. Research progress on antitumor activity of quercetin derivatives. China J. Chin. Mater. Med. 2020, 45, 3565–3574. [Google Scholar] [CrossRef]
- You, C.; Li, Y.-J.; Dong, Y.; Ning, L.; Zhang, Y.; Yao, L.; Wang, F. Low-Temperature Trigger Nitric Oxide Nanogenerators for Enhanced Mild Photothermal Therapy. ACS Biomater. Sci. Eng. 2020, 6, 1535–1542. [Google Scholar] [CrossRef]
- Fu, Z.; Williams, G.R.; Niu, S.; Wu, J.; Gao, F.; Zhang, X.; Yang, Y.; Li, Y.; Zhu, L.-M. Functionalized boron nanosheets as an intelligent nanoplatform for synergistic low-temperature photothermal therapy and chemotherapy. Nanoscale 2020, 12, 14739–14750. [Google Scholar] [CrossRef] [PubMed]
- Wang, B.-K.; Yu, X.-F.; Wang, J.-H.; Li, Z.-B.; Li, P.-H.; Wang, H.; Song, L.; Chu, P.K.; Li, C. Gold-nanorods-siRNA nanoplex for improved photothermal therapy by gene silencing. Biomaterials 2016, 78, 27–39. [Google Scholar] [CrossRef] [PubMed]
- Cao, Y.; Wu, T.; Zhang, K.; Meng, X.; Dai, W.; Wang, D.; Dong, H.; Zhang, X. Engineered Exosome-Mediated Near-Infrared-II Region V2C Quantum Dot Delivery for Nucleus-Target Low-Temperature Photothermal Therapy. ACS Nano 2019, 13, 1499–1510. [Google Scholar] [CrossRef] [PubMed]
- Jin, Y.; Liang, L.; Sun, X.; Yu, G.; Chen, S.; Shi, S.; Liu, H.; Li, Z.; Ge, K.; Liu, D.; et al. Deoxyribozyme-nanosponges for improved photothermal therapy by overcoming thermoresistance. NPG Asia Mater. 2018, 10, 373–384. [Google Scholar] [CrossRef] [Green Version]
- Gao, G.; Jiang, Y.-W.; Jia, H.-R.; Sun, W.; Guo, Y.; Yu, X.-W.; Liu, X.; Wu, F.-G. From perinuclear to intranuclear localization: A cell-penetrating peptide modification strategy to modulate cancer cell migration under mild laser irradiation and improve photothermal therapeutic performance. Biomaterials 2019, 223, 119443. [Google Scholar] [CrossRef]
- Huo, S.; Jin, S.; Ma, X.; Xue, X.; Yang, K.; Kumar, A.; Wang, P.C.; Zhang, J.; Hu, Z.; Liang, X.-J. Ultrasmall Gold Nanoparticles as Carriers for Nucleus-Based Gene Therapy Due to Size-Dependent Nuclear Entry. ACS Nano 2014, 8, 5852–5862. [Google Scholar] [CrossRef]
- Liu, Z.; Qiu, K.; Liao, X.; Rees, T.W.; Chen, Y.; Zhao, Z.; Ji, L.; Chao, H. Nucleus-targeting ultrasmall ruthenium(iv) oxide nanoparticles for photoacoustic imaging and low-temperature photothermal therapy in the NIR-II window. Chem. Commun. 2020, 56, 3019–3022. [Google Scholar] [CrossRef]
- Oronsky, B.T.; Oronsky, N.; Fanger, G.R.; Parker, C.W.; Caroen, S.; Lybeck, M.; Scicinski, J.J. Follow the ATP: Tumor Energy Production: A Perspective. Anti-Cancer Agents Med. Chem. 2014, 14, 1187–1198. [Google Scholar] [CrossRef]
- Wang, P.; Kankala, R.K.; Chen, B.; Zhang, Y.; Zhu, M.; Li, X.; Long, R.; Yang, D.; Krastev, R.; Wang, S.; et al. Cancer Cytomembrane-Cloaked Prussian Blue Nanoparticles Enhance the Efficacy of Mild-Temperature Photothermal Therapy by Disrupting Mitochondrial Functions of Cancer Cells. ACS Appl. Mater. Interfaces 2021, 13, 37563–37577. [Google Scholar] [CrossRef]
- Abdel-Wahab, A.F.; Mahmoud, W.; Al-Harizy, R.M. Targeting glucose metabolism to suppress cancer progression: Prospective of anti-glycolytic cancer therapy. Pharmacol. Res. 2019, 150, 104511. [Google Scholar] [CrossRef]
- Gao, G.; Jiang, Y.; Guo, Y.; Jia, H.; Cheng, X.; Deng, Y.; Yu, X.; Zhu, Y.; Guo, H.; Sun, W.; et al. Enzyme-Mediated Tumor Starvation and Phototherapy Enhance Mild-Temperature Photothermal Therapy. Adv. Funct. Mater. 2020, 30, 1909391. [Google Scholar] [CrossRef]
- Chen, W.-H.; Luo, G.-F.; Lei, Q.; Hong, S.; Qiu, W.-X.; Liu, L.-H.; Cheng, S.-X.; Zhang, X.-Z. Overcoming the Heat Endurance of Tumor Cells by Interfering with the Anaerobic Glycolysis Metabolism for Improved Photothermal Therapy. ACS Nano 2017, 11, 1419–1431. [Google Scholar] [CrossRef]
- Xin, Y.; Jiang, F.; Yang, C.; Yan, Q.; Guo, W.; Huang, Q.; Zhang, L.; Jiang, G. Role of autophagy in regulating the radiosensitivity of tumor cells. J. Cancer Res. Clin. Oncol. 2017, 143, 2147–2157. [Google Scholar] [CrossRef]
- Ke, P.-Y. Diverse Functions of Autophagy in Liver Physiology and Liver Diseases. Int. J. Mol. Sci. 2019, 20, 300. [Google Scholar] [CrossRef] [Green Version]
- Maes, H.; Kuchnio, A.; Carmeliet, P.; Agostinis, P. Chloroquine anticancer activity is mediated by autophagy-independent effects on the tumor vasculature. Mol. Cell. Oncol. 2016, 3, e970097. [Google Scholar] [CrossRef] [Green Version]
- Ishibashi, Y.; Nakamura, O.; Yamagami, Y.; Nishimura, H.; Fukuoka, N.; Yamamoto, T. Chloroquine Enhances Rapamycin-induced Apoptosis in MG63 Cells. Anticancer Res. 2019, 39, 649–654. [Google Scholar] [CrossRef]
- Zhou, Z.; Yan, Y.; Hu, K.; Zou, Y.; Li, Y.; Ma, R.; Zhang, Q.; Cheng, Y. Autophagy inhibition enabled efficient photothermal therapy at a mild temperature. Biomaterials 2017, 141, 116–124. [Google Scholar] [CrossRef]
- Zhou, Z.; Yan, Y.; Wang, L.; Zhang, Q.; Cheng, Y. Melanin-like nanoparticles decorated with an autophagy-inducing peptide for efficient targeted photothermal therapy. Biomaterials 2019, 203, 63–72. [Google Scholar] [CrossRef]
- Liu, Y.; Bhattarai, P.; Dai, Z.; Chen, X. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem. Soc. Rev. 2019, 48, 2053–2108. [Google Scholar] [CrossRef]
- Zhang, D.-Y.; Zheng, Y.; Zhang, H.; Sun, J.-H.; Tan, C.-P.; He, L.; Zhang, W.; Ji, L.-N.; Mao, Z.-W. Delivery of Phosphorescent Anticancer Iridium(III) Complexes by Polydopamine Nanoparticles for Targeted Combined Photothermal-Chemotherapy and Thermal/Photoacoustic/Lifetime Imaging. Adv. Sci. 2018, 5, 1800581–1800592. [Google Scholar] [CrossRef] [Green Version]
- Lei, G.; Mao, C.; Yan, Y.; Zhuang, L.; Gan, B. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell 2021, 12, 836–857. [Google Scholar] [CrossRef] [PubMed]
- Thakkar, S.; Sharma, D.; Kalia, K.; Tekade, R.K. Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review. Acta Biomater. 2020, 101, 43–68. [Google Scholar] [CrossRef] [PubMed]
- Francoa, P.I.R.; Rodrigues, A.P.; de Menezes, L.B.; Miguel, M.P. Tumor microenvironment components: Allies of cancer progression. Pathol. Res. Pract. 2020, 216, 152729. [Google Scholar] [CrossRef] [PubMed]
- Song, Y.; Wang, Y.; Zhu, Y.; Cheng, Y.; Wang, Y.; Wang, S.; Tan, F.; Lian, F.; Li, N. Biomodal Tumor-Targeted and Redox-Responsive Bi2Se3 Hollow Nanocubes for MSOT/CT Imaging Guided Synergistic Low-Temperature Photothermal Radiotherapy. Adv. Healthc. Mater. 2019, 8, e1900250. [Google Scholar] [CrossRef] [PubMed]
- Shi, S.; Wang, Y.; Wang, B.; Chen, Q.; Wan, G.; Yang, X.; Zhang, J.; Zhang, L.; Li, C.; Wang, Y. Homologous-targeting biomimetic nanoparticles for photothermal therapy and Nrf2-siRNA amplified photodynamic therapy against oral tongue squamous cell carcinoma. Chem. Eng. J. 2020, 388, 124268. [Google Scholar] [CrossRef]
- Hu, J.-J.; Lei, Q.; Zhang, X.-Z. Recent advances in photonanomedicines for enhanced cancer photodynamic therapy. Prog. Mater. Sci. 2020, 114, 100685. [Google Scholar] [CrossRef]
- Tabish, T.A.; Zhang, S.; Winyard, P.G. Developing the next generation of graphene-based platforms for cancer therapeutics: The potential role of reactive oxygen species. Redox Biol. 2018, 15, 34–40. [Google Scholar] [CrossRef]
- Hou, X.; Tao, Y.; Pang, Y.; Li, X.; Jiang, G.; Liu, Y. Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment. Int. J. Cancer 2018, 143, 3050–3060. [Google Scholar] [CrossRef] [Green Version]
- Wang, J.; Sun, J.; Hu, W.; Wang, Y.; Chou, T.; Zhang, B.; Zhang, Q.; Ren, L.; Wang, H. A Porous Au@Rh Bimetallic Core–Shell Nanostructure as an H2O2-Driven Oxygenerator to Alleviate Tumor Hypoxia for Simultaneous Bimodal Imaging and Enhanced Photodynamic Therapy. Adv. Mater. 2020, 32, 2001862. [Google Scholar] [CrossRef]
- Gan, S.; Tong, X.; Zhang, Y.; Wu, J.; Hu, Y.; Yuan, A. Covalent Organic Framework-Supported Molecularly Dispersed Near-Infrared Dyes Boost Immunogenic Phototherapy against Tumors. Adv. Funct. Mater. 2019, 29, 1902757. [Google Scholar] [CrossRef]
- Fan, H.Y.; Yu, X.H.; Wang, K.; Yin, Y.J.; Tang, Y.J.; Tang, Y.L.; Liang, X.H. Graphene quantum dots (GQDs)-based nanomaterials for improving photodynamic therapy in cancer treatment. Eur. J. Med. Chem. 2019, 182, 111620. [Google Scholar] [CrossRef]
- Cong, Z.; Zhang, L.; Ma, S.-Q.; Lam, K.S.; Yang, F.-F.; Liao, Y.-H. Size-Transformable Hyaluronan Stacked Self-Assembling Peptide Nanoparticles for Improved Transcellular Tumor Penetration and Photo–Chemo Combination Therapy. ACS Nano 2020, 14, 1958–1970. [Google Scholar] [CrossRef]
- Bao, Z.; Li, K.; Hou, P.; Xiao, R.; Yuan, Y.; Sun, Z. Nanoscale metal–organic framework composites for phototherapy and synergistic therapy of cancer. Mater. Chem. Front. 2021, 5, 1632–1654. [Google Scholar] [CrossRef]
- Li, X.; Kwon, N.; Guo, T.; Liu, Z.; Yoon, J. Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy. Angew. Chem. Int. Ed. 2018, 57, 11522–11531. [Google Scholar] [CrossRef]
- Sahu, A.; Kwon, I.; Tae, G. Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia. Biomaterials 2019, 228, 119578. [Google Scholar] [CrossRef]
- Zhang, K.; Meng, X.; Cao, Y.; Yang, Z.; Dong, H.; Zhang, Y.; Lu, H.; Shi, Z.; Zhang, X. Metal-Organic Framework Nanoshuttle for Synergistic Photodynamic and Low-Temperature Photothermal Therapy. Adv. Funct. Mater. 2018, 28, 1804634. [Google Scholar] [CrossRef]
- Jin, Q.; Deng, Y.; Jia, F.; Tang, Z.; Ji, J. Gas Therapy: An Emerging “Green” Strategy for Anticancer Therapeutics. Adv. Ther. 2018, 1, 1800084. [Google Scholar] [CrossRef]
- Zhang, H.; Xie, M.; Chen, H.; Bavi, S.; Sohail, M.; Bavi, R. Gas-mediated cancer therapy. Environ. Chem. Lett. 2020, 19, 149–166. [Google Scholar] [CrossRef]
- Wang, L.; Kang, K.; Ma, Y.; Zhang, F.; Guo, W.; Yu, K.; Wang, K.; Qu, F.; Lin, H. In-situ NO release and conversion for highly efficient synergistic gas therapy and phototherapy. Chem. Eng. J. 2022, 444, 136512. [Google Scholar] [CrossRef]
- Luo, G.; Li, Z.; Chen, M.; Zheng, J.; Deng, X.; Xu, G.; Cheng, M.; Li, X.; Duo, Y. Three-staged tumor inhibition by mitochondria-targeted cascaded gas/mild-photothermal/photodynamic synergistic therapy. Chem. Eng. J. 2022, 442, 136169. [Google Scholar] [CrossRef]
- Wang, Y.; Yang, T.; He, Q. Strategies for engineering advanced nanomedicines for gas therapy of cancer. Natl. Sci. Rev. 2020, 7, 1485–1512. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Li, S.; Wang, X.; Chen, Q.; He, Z.; Luo, C.; Sun, J. Smart transformable nanomedicines for cancer therapy. Biomaterials 2021, 271, 120737. [Google Scholar] [CrossRef] [PubMed]
- Sun, W.; Wen, Y.; Thiramanas, R.; Chen, M.; Han, J.; Gong, N.; Wagner, M.; Jiang, S.; Meijer, M.; Bonnet, S.; et al. Red-Light-Controlled Release of Drug-Ru Complex Conjugates from Metallopolymer Micelles for Phototherapy in Hypoxic Tumor Environments. Adv. Funct. Mater. 2018, 28, 1804227. [Google Scholar] [CrossRef] [Green Version]
- Huang, Y.; Huang, J.; Jiang, M.; Zeng, S. NIR-Triggered Theranostic Bi2S3 Light Transducer for On-Demand NO Release and Synergistic Gas/Photothermal Combination Therapy of Tumors. ACS Appl. Bio. Mater. 2019, 2, 4769–4776. [Google Scholar] [CrossRef] [PubMed]
- Lu, Q.; Lu, T.; Xu, M.; Yang, L.; Song, Y.; Li, N. SO2 prodrug doped nanorattles with extra-high drug payload for “collusion inside and outside” photothermal/pH triggered–gas therapy. Biomaterials 2020, 257, 120236. [Google Scholar] [CrossRef]
- Ding, Y.; Du, C.; Qian, J.; Dong, C.-M. NIR-Responsive Polypeptide Nanocomposite Generates NO Gas, Mild Photothermia, and Chemotherapy to Reverse Multidrug-Resistant Cancer. Nano Lett. 2019, 19, 4362–4370. [Google Scholar] [CrossRef]
- Li, J.; Jiang, R.; Wang, Q.; Li, X.; Hu, X.; Yuan, Y.; Lu, X.; Wang, W.; Huang, W.; Fan, Q. Semiconducting polymer nanotheranostics for NIR-II/Photoacoustic imaging-guided photothermal initiated nitric oxide/photothermal therapy. Biomaterials 2019, 217, 119304. [Google Scholar] [CrossRef]
- Guo, R.; Tian, Y.; Wang, Y.; Yang, W. Near-Infrared Laser-Triggered Nitric Oxide Nanogenerators for the Reversal of Multidrug Resistance in Cancer. Adv. Funct. Mater. 2017, 27, 1606398. [Google Scholar] [CrossRef]
- Ghoneim, H.E.; Fan, Y.; Moustaki, A.; Abdelsamed, H.A.; Dash, P.; Dogra, P.; Carter, R.; Awad, W.; Neale, G.; Thomas, P.G.; et al. De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation. Cell 2017, 170, 142–157.e19. [Google Scholar] [CrossRef] [Green Version]
- Jia, X.; Yan, B.; Tian, X.; Liu, Q.; Jin, J.; Shi, J.; Hou, Y. CD47/SIRPα pathway mediates cancer immune escape and immunotherapy. Int. J. Biol. Sci. 2021, 17, 3281–3287. [Google Scholar] [CrossRef]
- Lu, J.; Jiao, Y.; Cao, G.; Liu, Z. Multimode CaCO3/pneumolysin antigen delivery systems for inducing efficient cellular immunity for anti-tumor immunotherapy. Chem. Eng. J. 2021, 420, 129746. [Google Scholar] [CrossRef]
- Tang, S.; Ning, Q.; Yang, L.; Mo, Z.; Tang, S. Mechanisms of immune escape in the cancer immune cycle. Int. Immunopharmacol. 2020, 86, 106700. [Google Scholar] [CrossRef]
- Chen, D.S.; Mellman, I. Oncology Meets Immunology: The Cancer-Immunity Cycle. Immunity 2013, 39, 1–10. [Google Scholar] [CrossRef] [Green Version]
- Wang, M.; Rao, J.; Wang, M.; Li, X.; Liu, K.; Naylor, M.F.; Nordquist, R.E.; Chen, W.R.; Zhou, F. Cancer photo-immunotherapy: From bench to bedside. Theranostics 2021, 11, 2218–2231. [Google Scholar] [CrossRef]
- Li, J.; Yu, X.; Jiang, Y.; He, S.; Zhang, Y.; Luo, Y.; Pu, K. Second Near-Infrared Photothermal Semiconducting Polymer Nanoadjuvant for Enhanced Cancer Immunotherapy. Adv. Mater. 2021, 33, e2003458. [Google Scholar] [CrossRef]
- Cano-Mejia, J.; Burga, R.A.; Sweeney, E.E.; Fisher, J.P.; Bollard, C.M.; Sandler, A.D.; Cruz, C.R.Y.; Fernandes, R. Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma. Nanomed. Nanotechnol. Biol. Med. 2017, 13, 771–781. [Google Scholar] [CrossRef]
- Dong, X.; Liang, J.; Yang, A.; Qian, Z.; Kong, D.; Lv, F. Fluorescence imaging guided CpG nanoparticles-loaded IR820-hydrogel for synergistic photothermal immunotherapy. Biomaterials 2019, 209, 111–125. [Google Scholar] [CrossRef]
- Li, S.; Zhang, W.; Xing, R.; Yuan, C.; Xue, H.; Yan, X. Supramolecular Nanofibrils Formed by Coassembly of Clinically Approved Drugs for Tumor Photothermal Immunotherapy. Adv. Mater. 2021, 33, 2103733. [Google Scholar] [CrossRef]
- Shang, T.; Yu, X.; Han, S.; Yang, B. Nanomedicine-based tumor photothermal therapy synergized immunotherapy. Biomater. Sci. 2020, 8, 5241–5259. [Google Scholar] [CrossRef]
- Li, Y.; Zhang, K.; Wu, Y.; Yue, Y.; Cheng, K.; Feng, Q.; Ma, X.; Liang, J.; Ma, N.; Liu, G.; et al. Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ Vaccine for Cancer Immunotherapy Post-Photothermal Therapy. Small 2022, 18, 2107461. [Google Scholar] [CrossRef]
- Wang, J.; Hu, X.; Xiang, D. Nanoparticle drug delivery systems: An excellent carrier for tumor peptide vaccines. Drug Deliv. 2018, 25, 1319–1327. [Google Scholar] [CrossRef] [PubMed]
- Jiang, J.; Mei, J.; Yi, S.; Feng, C.; Ma, Y.; Liu, Y.; Liu, Y.; Chen, C. Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery. Adv. Drug Deliv. Rev. 2021, 180, 114046. [Google Scholar] [CrossRef] [PubMed]
- Chen, J.; Zhang, H.; Zhou, L.; Hu, Y.; Li, M.; He, Y.; Li, Y. Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms. Front. Oncol. 2021, 10, 584367. [Google Scholar] [CrossRef] [PubMed]
- Suckow, M.A. Cancer vaccines: Harnessing the potential of anti-tumor immunity. Veter. J. 2013, 198, 28–33. [Google Scholar] [CrossRef] [PubMed]
- Scheiermann, J.; Klinman, D.M. Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer. Vaccine 2014, 32, 6377–6389. [Google Scholar] [CrossRef] [Green Version]
- Yang, R.; Zhou, S.; Zhou, Q. In vitro naphthylquinoxaline thymidine conjugate and UVA treated cancer cells are effective therapeutic vaccines for tumors in vivo with CpG as the adjuvant. J. Adv. Res. 2022, 35, 259–266. [Google Scholar] [CrossRef]
- Lubaroff, D.M.; Karan, D. CpG oligonucleotide as an adjuvant for the treatment of prostate cancer. Adv. Drug Deliv. Rev. 2009, 61, 268–274. [Google Scholar] [CrossRef]
- Lai, C.-Y.; Yu, G.-Y.; Luo, Y.; Xiang, R.; Chuang, T.-H. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21. Front. Immunol. 2019, 10, 179. [Google Scholar] [CrossRef]
- Jin, Y.; Zhuang, Y.; Dong, X.; Liu, M. Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy. Expert Rev. Anticancer Ther. 2021, 21, 841–851. [Google Scholar] [CrossRef]
- Li, Y.; He, L.; Dong, H.; Liu, Y.; Wang, K.; Li, A.; Ren, T.; Shi, D.; Li, Y. Fever-Inspired Immunotherapy Based on Photothermal CpG Nanotherapeutics: The Critical Role of Mild Heat in Regulating Tumor Microenvironment. Adv. Sci. 2018, 5, 1700805. [Google Scholar] [CrossRef] [Green Version]
- Geraud, A.; Gougis, P.; Vozy, A.; Anquetil, C.; Allenbach, Y.; Romano, E.; Funck-Brentano, E.; Moslehi, J.J.; Johnson, D.B.; Salem, J.-E. Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance. Annu. Rev. Pharmacol. Toxicol. 2021, 61, 85–112. [Google Scholar] [CrossRef]
- Toor, S.M.; Nair, V.S.; Decock, J.; Elkord, E. Immune checkpoints in the tumor microenvironment. Semin. Cancer Biol. 2020, 65, 1–12. [Google Scholar] [CrossRef]
- Bonaventura, P.; Shekarian, T.; Alcazer, V.; Valladeau-Guilemond, J.; Valsesia-Wittmann, S.; Amigorena, S.; Caux, C.; Depil, S. Cold Tumors: A Therapeutic Challenge for Immunotherapy. Front. Immunol. 2019, 10, 168. [Google Scholar] [CrossRef] [Green Version]
- Fan, Z.; Liu, H.; Xue, Y.; Lin, J.; Fu, Y.; Xia, Z.; Pan, D.; Zhang, J.; Qiao, K.; Zhang, Z.; et al. Reversing cold tumors to hot: An immunoadjuvant-functionalized metal-organic framework for multimodal imaging-guided synergistic photo-immunotherapy. Bioact. Mater. 2021, 6, 312–325. [Google Scholar] [CrossRef]
- Galon, J.; Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 2019, 18, 197–218. [Google Scholar] [CrossRef]
- Rossi, C.; Gilhodes, J.; Maerevoet, M.; Herbaux, C.; Morschhauser, F.; Brice, P.; Garciaz, S.; Borel, C.; Ysebaert, L.; Obéric, L.; et al. Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers. Am. J. Hematol. 2018, 93, 1042–1049. [Google Scholar] [CrossRef] [Green Version]
- Wang, C.; Wang, J.; Zhang, X.; Yu, S.; Wen, D.; Hu, Q.; Ye, Y.; Bomba, H.; Hu, X.; Liu, Z.; et al. In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy. Sci. Transl. Med. 2018, 10, eaan3682. [Google Scholar] [CrossRef] [Green Version]
- Jia, C.; Zhang, F.; Lin, J.; Feng, L.; Wang, T.; Feng, Y.; Yuan, F.; Mai, Y.; Zeng, X.; Zhang, Q. Black phosphorus-Au-thiosugar nanosheets mediated photothermal induced anti-tumor effect enhancement by promoting infiltration of NK cells in hepatocellular carcinoma. J. Nanobiotechnol. 2022, 20, 90. [Google Scholar] [CrossRef]
- Huang, L.; Li, Y.; Du, Y.; Zhang, Y.; Wang, X.; Ding, Y.; Yang, X.; Meng, F.; Tu, J.; Luo, L.; et al. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy. Nat. Commun. 2019, 10, 4871. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wang, P.; Chen, B.; Zhan, Y.; Wang, L.; Luo, J.; Xu, J.; Zhan, L.; Li, Z.; Liu, Y.; Wei, J. Enhancing the Efficiency of Mild-Temperature Photothermal Therapy for Cancer Assisting with Various Strategies. Pharmaceutics 2022, 14, 2279. https://doi.org/10.3390/pharmaceutics14112279
Wang P, Chen B, Zhan Y, Wang L, Luo J, Xu J, Zhan L, Li Z, Liu Y, Wei J. Enhancing the Efficiency of Mild-Temperature Photothermal Therapy for Cancer Assisting with Various Strategies. Pharmaceutics. 2022; 14(11):2279. https://doi.org/10.3390/pharmaceutics14112279
Chicago/Turabian StyleWang, Pei, Biaoqi Chen, Yunyan Zhan, Lianguo Wang, Jun Luo, Jia Xu, Lilin Zhan, Zhihua Li, Yuangang Liu, and Junchao Wei. 2022. "Enhancing the Efficiency of Mild-Temperature Photothermal Therapy for Cancer Assisting with Various Strategies" Pharmaceutics 14, no. 11: 2279. https://doi.org/10.3390/pharmaceutics14112279
APA StyleWang, P., Chen, B., Zhan, Y., Wang, L., Luo, J., Xu, J., Zhan, L., Li, Z., Liu, Y., & Wei, J. (2022). Enhancing the Efficiency of Mild-Temperature Photothermal Therapy for Cancer Assisting with Various Strategies. Pharmaceutics, 14(11), 2279. https://doi.org/10.3390/pharmaceutics14112279